Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Camilla Suzanne Graham, M.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. K08DA014495 (GRAHAM, CAMILLA S) Jul 1, 2001 - Jun 30, 2007
    Cellular Immunity to Hepatitis C Virus in HIV
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Graham CS. The Current Status of US and Global Access to Direct-Acting Antiviral Regimens for Hepatitis C Virus Infection. Clin Liver Dis (Hoboken). 2020 Jul; 16(1):16-19. PMID: 32714518; PMCID: PMC7373775.
    Citations: 6     
  2. Graham CS, Trooskin S. Universal Screening for Hepatitis C Virus Infection: A Step Toward Elimination. JAMA. 2020 03 10; 323(10):936-937. PMID: 32119041.
    Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
  3. Graham CS, Trooskin SB. Removing the Barriers from the Path to Eliminate Hepatitis C. Infect Dis Clin North Am. 2018 06; 32(2):xv-xvi. PMID: 29778268.
    Citations:    Fields:    
  4. Tolan NV, Horowitz GL, Graham CS, Hillyard D, Osburn W, Ray S. New Therapies for Treating Hepatitis C Virus: Impact on Laboratory Testing Recommendations and Clinical Management. Clin Chem. 2017 12; 63(12):1799-1805. PMID: 29018029.
    Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
  5. Graham CS. Making Do With What We Have. Ann Intern Med. 2017 06 06; 166(11):850-851. PMID: 28437798.
    Citations:    Fields:    Translation:Humans
  6. Clements KM, Clark RE, Lavitas P, Kunte P, Graham CS, O'Connell E, Lenz K, Jeffrey P. Access to New Medications for Hepatitis C for Medicaid Members: A Retrospective Cohort Study. J Manag Care Spec Pharm. 2016 Jun; 22(6):714-722b. PMID: 27231798.
    Citations: 8     Fields:    Translation:Humans
  7. Rosenthal ES, Graham CS. Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States. Infect Agent Cancer. 2016; 11:24. PMID: 27186235; PMCID: PMC4867525.
    Citations: 41     
  8. Graham CS. Hepatitis C and HIV co-infection: closing the gaps. JAMA. 2015 Mar 24-31; 313(12):1217-8. PMID: 25705993.
    Citations: 3     Fields:    Translation:HumansCells
  9. Graham CS, Swan T. A path to eradication of hepatitis C in low- and middle-income countries. Antiviral Res. 2015 Jul; 119:89-96. PMID: 25615583.
    Citations: 42     Fields:    Translation:HumansPHPublic Health
  10. Tomaszewski KJ, Deniz B, Tomanovich P, Graham CS. Comparison of current US risk strategy to screen for hepatitis C virus with a hypothetical targeted birth cohort strategy. Am J Public Health. 2012 Nov; 102(11):e101-6. PMID: 22813094; PMCID: PMC3477967.
    Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
  11. Reed C, Stuver SO, Tumilty S, Nunes D, Murray JE, Graham CS, James Koziel M, Craven DE, Skolnik PR, Horsburgh CR. Predictors of treatment for hepatitis C virus (HCV) infection in drug users. Subst Abus. 2008; 29(1):5-15. PMID: 19042314.
    Citations: 1     Fields:    Translation:Humans
  12. Alatrakchi N, Graham CS, van der Vliet HJ, Sherman KE, Exley MA, Koziel MJ. Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses. J Virol. 2007 Jun; 81(11):5882-92. PMID: 17376924; PMCID: PMC1900307.
    Citations: 44     Fields:    Translation:HumansCells
  13. Graham CS, Wells A, Edwards EM, Herren T, Tumilty S, Stuver SO, Samet JH, Nunes D, Horsburgh CR, Koziel MJ. Effect of exposure to injection drugs or alcohol on antigen-specific immune responses in HIV and hepatitis C virus coinfection. J Infect Dis. 2007 Mar 15; 195(6):847-56. PMID: 17299715.
    Citations: 8     Fields:    Translation:Humans
  14. He Q, Graham CS, Durante Mangoni E, Koziel MJ. Differential expression of toll-like receptor mRNA in treatment non-responders and sustained virologic responders at baseline in patients with chronic hepatitis C. Liver Int. 2006 Nov; 26(9):1100-10. PMID: 17032411.
    Citations: 12     Fields:    Translation:HumansCells
  15. Graham CS, Wells A, Liu T, Sherman KE, Peters M, Chung RT, Bhan AK, Andersen J, Koziel MJ. Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection. AIDS. 2006 Feb 14; 20(3):345-51. PMID: 16439867; PMCID: PMC4060610.
    Citations: 3     Fields:    Translation:Humans
  16. Graham CS, Wells A, Liu T, Sherman KE, Peters M, Chung RT, Bhan AK, Andersen J, Koziel MJ. Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection. AIDS. 2005 May 20; 19(8):767-73. PMID: 15867490; PMCID: PMC4050654.
    Citations: 13     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
  17. Alatrakchi N, Graham CS, He Q, Sherman KE, Koziel MJ. CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection. J Infect Dis. 2005 Mar 01; 191(5):702-9. PMID: 15688283.
    Citations: 15     Fields:    Translation:HumansCells
  18. Kamal SM, Amin A, Madwar M, Graham CS, He Q, Al Tawil A, Rasenack J, Nakano T, Robertson B, Ismail A, Koziel MJ. Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients. J Virol. 2004 Nov; 78(22):12252-8. PMID: 15507612; PMCID: PMC525051.
    Citations: 22     Fields:    Translation:HumansCells
  19. Graham CS, Curry M, He Q, Afdhal N, Nunes D, Fleming C, Horsburgh R, Craven D, Sherman KE, Koziel MJ. Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV. Hepatology. 2004 Jul; 40(1):125-32. PMID: 15239095.
    Citations: 25     Fields:    Translation:HumansCells
  20. Kamal SM, Ismail A, Graham CS, He Q, Rasenack JW, Peters T, Tawil AA, Fehr JJ, Khalifa Kel S, Madwar MM, Koziel MJ. Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics. Hepatology. 2004 Jun; 39(6):1721-31. PMID: 15185314.
    Citations: 39     Fields:    Translation:HumansCellsCTClinical Trials
  21. Kamal SM, Graham CS, He Q, Bianchi L, Tawil AA, Rasenack JW, Khalifa KA, Massoud MM, Koziel MJ. Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis. J Infect Dis. 2004 Apr 01; 189(7):1140-50. PMID: 15031780.
    Citations: 29     Fields:    Translation:HumansAnimalsCells
  22. Fleming CA, Christiansen D, Nunes D, Heeren T, Thornton D, Horsburgh CR, Koziel MJ, Graham C, Craven DE. Health-related quality of life of patients with HIV disease: impact of hepatitis C coinfection. Clin Infect Dis. 2004 Feb 15; 38(4):572-8. PMID: 14765352.
    Citations: 25     Fields:    Translation:Humans
  23. Schwaber MJ, Graham CS, Sands BE, Gold HS, Carmeli Y. Treatment with a broad-spectrum cephalosporin versus piperacillin-tazobactam and the risk for isolation of broad-spectrum cephalosporin-resistant Enterobacter species. Antimicrob Agents Chemother. 2003 Jun; 47(6):1882-6. PMID: 12760862.
    Citations: 7     Fields:    Translation:HumansCells
  24. Graham CS, Koziel MJ. First things first: balancing hepatitis C and human immunodeficiency virus. Clin Infect Dis. 2003 Feb 01; 36(3):368-9. PMID: 12539080.
    Citations:    Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Graham's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (125)
Co-Authors (8)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.